Linden Thomas Advisory Services’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$933K Buy
272,661
+32,282
+13% +$100K 0.08% 348
2026
Q1
$548K Buy
240,379
+121,865
+103% +$281K 0.05% 384
2025
Q4
$332K Sell
118,514
-2,721
-2% -$9.72K 0.03% 417
2025
Q3
$582K Buy
121,235
+5,049
+4% +$32.1K 0.06% 377
2025
Q2
$1.06M Buy
116,186
+84,948
+272% +$626K 0.12% 274
2025
Q1
$282K Buy
31,238
+4,936
+19% +$52.1K 0.04% 422
2024
Q4
$344K Buy
26,302
+3,688
+16% +$49.2K 0.04% 412
2024
Q3
$355K Buy
22,614
+3,472
+18% +$52.6K 0.05% 405
2024
Q2
$258K Buy
19,142
+1,764
+10% +$36.1K 0.04% 411
2024
Q1
$482K Buy
17,378
+3,473
+25% +$77.1K 0.08% 344
2023
Q4
$268K Buy
13,905
+2,944
+27% +$53.3K 0.05% 377
2023
Q3
$177K Sell
10,961
-41
-0.4% -$728 0.04% 380
2023
Q2
$209K Buy
+11,002
New +$196K 0.05% 351

Other funds holding ACH

Linden Thomas Advisory Services's ACH Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Accendra Health (ACH) stake by 13% in Q2 2026, buying an estimated $100K and bringing the position to 272,661 shares worth $933K. The position accounts for 0.08% of the portfolio, ranked #348.

Linden Thomas Advisory Services first reported a position in ACH in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.06M in Q2 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Linden Thomas Advisory Services held 272,661 shares of Accendra Health worth $933K as of Q2 2026.
  • Linden Thomas Advisory Services bought 32,282 Accendra Health shares in Q2 2026, an estimated $100K.
  • Accendra Health made up 0.08% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #348 holding.
  • Linden Thomas Advisory Services first reported a position in Accendra Health in Q2 2023 and has held it in 13 quarters since.
  • Linden Thomas Advisory Services's Accendra Health position peaked at $1.06M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.